Xponential Fitness (XPOF) Financials

$5.54 +0.08 (+1.37%)

Closing price 03:59 PM Eastern

Extended Trading

$5.58 +0.03 (+0.54%)

As of 04:10 PM Eastern

Annual Income Statements for Xponential Fitness

This table shows Xponential Fitness' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	1.22	-4.00	-68
Consolidated Net Income / (Loss)	1.10	-6.44	-99
Net Income / (Loss) Continuing Operations	7.81	-6.44	-99
Total Pre-Tax Income	1.59	-5.41	-99
Total Operating Income	13	35	-54
Total Gross Profit	197	242	239
Total Revenue	243	318	320
Operating Revenue	243	318	320
Total Cost of Revenue	46	76	81
Operating Cost of Revenue	46	76	81
Total Operating Expenses	166	207	293
Selling, General & Admin Expense	127	169	177
Marketing Expense	17	23	27
Depreciation Expense	15	17	18
Other Operating Expenses / (Income)	2.44	-18	8.89
Impairment Charge	3.66	17	63
Total Other Income / (Expense), net	-23	-40	-45
Interest Expense	13	39	46
Interest & Investment Income	1.81	1.61	1.82
Other Income / (Expense), net	-12	-3.19	-1.00
Income Tax Expense	0.49	1.03	-0.34
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.11	-2.44	-31
Basic Earnings per Share	($0.88)	$1.08	($2.27)
Weighted Average Basic Shares Outstanding	25.30M	31.74M	32.00M
Diluted Earnings per Share	($0.88)	($0.52)	($2.27)
Weighted Average Diluted Shares Outstanding	25.30M	39.71M	32.00M
Weighted Average Basic & Diluted Shares Outstanding	49.27M	47.49M	48.48M

This table shows Xponential Fitness' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-7.14	-0.96	-9.98	18	-3.38	-9.02	-2.87	-9.10	-12	-44
Consolidated Net Income / (Loss)	-13	-2.14	-15	28	-5.18	-14	-4.36	-14	-18	-63
Net Income / (Loss) Continuing Operations	-13	4.57	-15	28	-5.18	-14	-4.36	-14	-18	-63
Total Pre-Tax Income	-13	-1.50	-15	28	-4.98	-13	-4.40	-14	-18	-63
Total Operating Income	10	-18	-7.21	36	7.48	-1.82	7.39	-2.41	-6.43	-52
Total Gross Profit	47	72	53	59	64	65	60	58	59	63
Total Revenue	64	70	71	77	80	89	80	77	80	84
Operating Revenue	64	70	71	77	80	89	80	77	80	84
Total Cost of Revenue	17	-2.09	18	18	16	24	20	19	22	21
Operating Cost of Revenue	17	-2.09	18	18	16	24	20	19	22	21
Total Operating Expenses	58	51	60	23	57	67	53	60	65	115
Selling, General & Admin Expense	33	31	35	37	44	53	37	37	46	57
Marketing Expense	4.26	4.59	5.01	5.47	5.82	6.39	6.52	7.85	6.42	5.89
Depreciation Expense	4.15	4.09	4.20	4.29	4.22	4.18	4.44	4.52	4.23	4.53
Other Operating Expenses / (Income)	16	8.23	16	-31	-1.92	-1.03	4.52	-1.22	3.66	1.92
Total Other Income / (Expense), net	-2.93	-15	-7.90	-8.80	-12	-11	-12	-11	-11	-11
Interest Expense	3.33	3.96	7.98	8.63	11	11	12	11	12	12
Interest & Investment Income	0.40	0.60	0.64	0.53	0.02	0.42	0.36	0.39	0.48	0.59
Other Income / (Expense), net	-	-	-0.55	-0.70	-1.85	-0.10	-0.61	-0.25	-0.05	-0.09
Income Tax Expense	-0.31	0.65	-0.12	0.13	0.20	0.82	-0.05	0.13	0.13	-0.56
Net Income / (Loss) Attributable to Noncontrolling Interest	-5.92	-1.18	-5.00	9.15	-1.80	-4.79	-1.49	-4.56	-5.97	-19
Basic Earnings per Share	($1.53)	($1.12)	($1.38)	$1.44	$0.91	$0.11	($0.30)	($0.29)	($0.29)	($1.39)
Weighted Average Basic Shares Outstanding	26.16M	25.30M	30.75M	33.05M	32.26M	31.74M	31.13M	31.81M	32.18M	32.00M
Diluted Earnings per Share	($1.53)	$1.66	($1.38)	$0.09	($0.50)	$1.27	($0.30)	($0.29)	($0.29)	($1.39)
Weighted Average Diluted Shares Outstanding	26.16M	25.30M	30.75M	41.59M	40.22M	39.71M	31.13M	31.81M	32.18M	32.00M
Weighted Average Basic & Diluted Shares Outstanding	49.22M	49.27M	49.56M	49.97M	47.46M	47.49M	48.07M	48.18M	48.30M	48.48M

This table details how cash moves in and out of Xponential Fitness' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	16	-0.28	-4.36
Net Cash From Operating Activities	52	33	12
Net Cash From Continuing Operating Activities	52	33	12
Net Income / (Loss) Continuing Operations	1.10	-6.44	-99
Consolidated Net Income / (Loss)	1.10	-6.44	-99
Depreciation Expense	15	17	18
Amortization Expense	0.74	3.41	4.36
Non-Cash Adjustments To Reconcile Net Income	33	47	74
Changes in Operating Assets and Liabilities, net	1.41	-28	14
Net Cash From Investing Activities	-15	-12	-14
Net Cash From Continuing Investing Activities	-15	-12	-14
Purchase of Property, Plant & Equipment	-8.96	-7.43	-4.71
Acquisitions	-7.18	-4.35	-10
Sale of Property, Plant & Equipment	3.30	0.84	0.88
Other Investing Activities, net	-1.78	-0.75	0.00
Net Cash From Financing Activities	-21	-21	-1.88
Net Cash From Continuing Financing Activities	-21	-21	-1.88
Repayment of Debt	-3.03	-4.61	-44
Repurchase of Preferred Equity	0.00	-131	0.00
Repurchase of Common Equity	0.00	-50	0.00
Payment of Dividends	-17	-19	-15
Issuance of Debt	7.43	189	63
Issuance of Preferred Equity	0.00	0.00	0.00
Issuance of Common Equity	0.00	0.00	0.21
Other Financing Activities, net	-9.15	-5.36	-6.16
Cash Interest Paid	12	35	41
Cash Income Taxes Paid	2.79	1.57	0.56

This table details how cash moves in and out of Xponential Fitness' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	1.63	6.48	-9.24	12	12	-15	-9.88	-1.20	12	-5.04
Net Cash From Operating Activities	11	15	11	19	7.63	-5.48	2.70	3.00	5.22	0.76
Net Cash From Continuing Operating Activities	11	15	11	19	7.63	-5.48	2.70	3.00	5.22	0.76
Net Income / (Loss) Continuing Operations	-13	-2.14	-15	28	-5.18	-14	-4.36	-14	-18	-63
Consolidated Net Income / (Loss)	-13	-2.14	-15	28	-5.18	-14	-4.36	-14	-18	-63
Depreciation Expense	4.15	4.09	4.20	4.29	4.22	4.18	4.44	4.52	4.23	4.53
Amortization Expense	0.75	-1.26	0.89	0.62	0.93	0.96	1.40	0.93	0.98	1.05
Non-Cash Adjustments To Reconcile Net Income	7.89	7.22	6.77	16	14	11	2.92	15	9.78	46
Changes in Operating Assets and Liabilities, net	12	6.69	14	-29	-5.88	-7.54	-1.70	-4.19	8.20	12
Net Cash From Investing Activities	-5.94	-3.04	-2.39	-3.23	-2.98	-3.09	-9.20	-2.56	-2.17	-0.22
Net Cash From Continuing Investing Activities	-5.94	-3.04	-2.39	-3.23	-2.98	-3.09	-9.20	-2.56	-2.17	-0.22
Purchase of Property, Plant & Equipment	-1.27	-3.30	-2.13	-2.23	-1.80	-1.27	-0.86	-2.13	-1.83	0.10
Acquisitions	-5.93	-0.34	-0.47	-0.96	-0.99	-1.93	-9.01	-0.51	-0.42	-0.38
Sale of Property, Plant & Equipment	1.67	0.59	0.21	0.16	0.35	0.11	0.66	0.08	0.08	0.06
Net Cash From Financing Activities	-3.71	-5.08	-18	-3.93	7.04	-6.21	-3.37	-1.65	8.71	-5.58
Net Cash From Continuing Financing Activities	-3.71	-5.08	-18	-3.93	7.04	-6.21	-3.37	-1.65	8.71	-5.58
Repayment of Debt	-0.74	-0.76	-1.18	-0.76	-1.49	-1.19	-40	-1.29	-1.40	-1.35
Payment of Dividends	-3.25	-3.64	-1.32	-1.82	-10	-6.17	-1.91	-0.30	-8.54	-3.94
Issuance of Common Equity	-	-	-	-	-	-	-	-	-	0.14
Other Financing Activities, net	-5.20	-2.62	-11	-1.35	5.88	1.15	0.00	-0.14	-5.60	-0.43
Cash Interest Paid	2.99	3.62	7.04	7.92	9.67	10	9.86	10	11	10
Cash Income Taxes Paid	0.57	0.22	0.55	0.55	0.57	-0.11	0.06	0.35	0.18	-0.02

This table presents Xponential Fitness' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	483	530	403
Total Current Assets	86	97	84
Cash & Equivalents	37	37	33
Note & Lease Receivable	1.52	0.20	0.23
Accounts Receivable	26	32	32
Inventories, net	11	16	10
Prepaid Expenses	6.29	5.59	4.87
Other Current Assets	4.13	6.89	4.60
Plant, Property, & Equipment, net	19	20	15
Total Noncurrent Assets	378	413	305
Noncurrent Note & Lease Receivables	1.07	0.80	0.10
Goodwill	166	171	135
Intangible Assets	137	120	101
Other Noncurrent Operating Assets	74	121	68
Total Liabilities & Shareholders' Equity	483	530	403
Total Liabilities	383	624	597
Total Current Liabilities	73	102	108
Short-Term Debt	3.04	4.76	5.40
Accounts Payable	16	19	27
Accrued Expenses	12	20	31
Current Deferred Revenue	32	35	26
Other Current Liabilities	9.27	24	18
Total Noncurrent Liabilities	310	522	490
Long-Term Debt	133	319	342
Noncurrent Deferred Revenue	109	117	106
Other Noncurrent Operating Liabilities	67	86	42
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	308	115	117
Total Equity & Noncontrolling Interests	-208	-210	-311
Total Preferred & Common Equity	-155	-130	-217
Preferred Stock	0.00	0.00	0.00
Total Common Equity	-155	-130	-217
Common Stock	505	521	504
Retained Earnings	-642	-634	-702
Treasury Stock	-1.70	-1.70	-1.70
Other Equity Adjustments	-16	-15	-17
Noncontrolling Interest	-53	-80	-94

This table presents Xponential Fitness' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	472	484	545	551	508	475	472
Total Current Assets	80	79	97	117	88	86	96
Cash & Equivalents	31	28	40	52	27	26	38
Note & Lease Receivable	1.93	1.50	1.50	1.11	0.07	0.35	0.28
Accounts Receivable	19	22	27	28	32	30	30
Inventories, net	14	13	12	16	15	13	11
Prepaid Expenses	11	9.92	12	14	5.66	8.24	8.34
Other Current Assets	3.57	4.08	4.26	6.51	7.33	8.07	9.02
Plant, Property, & Equipment, net	17	19	21	20	19	19	19
Total Noncurrent Assets	375	386	427	414	401	371	358
Noncurrent Note & Lease Receivables	3.11	0.85	0.64	1.18	0.65	0.11	0.10
Goodwill	166	166	171	166	174	163	163
Intangible Assets	140	135	125	122	124	120	118
Other Noncurrent Operating Assets	67	85	131	125	103	88	77
Total Liabilities & Shareholders' Equity	472	484	545	551	508	475	472
Total Liabilities	396	536	568	628	600	576	596
Total Current Liabilities	81	77	100	102	92	92	94
Short-Term Debt	3.04	4.26	4.26	5.20	5.15	5.15	5.40
Accounts Payable	23	19	27	24	25	23	21
Accrued Expenses	19	14	15	13	13	14	21
Current Deferred Revenue	29	31	35	37	30	29	29
Other Current Liabilities	6.62	8.55	20	22	19	20	17
Total Noncurrent Liabilities	315	459	467	527	508	484	501
Long-Term Debt	132	258	257	319	319	318	342
Noncurrent Deferred Revenue	108	111	113	115	116	111	109
Other Noncurrent Operating Liabilities	75	90	97	92	73	54	51
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	257	227	182	130	123	123	117
Total Equity & Noncontrolling Interests	-181	-279	-204	-207	-214	-224	-240
Total Preferred & Common Equity	-127	-223	-158	-138	-144	-152	-156
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-127	-223	-158	-138	-144	-152	-156
Common Stock	529	438	486	503	506	508	517
Retained Earnings	-642	-639	-621	-624	-633	-642	-654
Treasury Stock	-	-1.70	-1.70	-1.70	-1.70	-1.70	-1.70
Other Equity Adjustments	-14	-20	-22	-15	-16	-16	-17
Noncontrolling Interest	-54	-56	-46	-69	-70	-72	-84

This table displays calculated financial ratios and metrics derived from Xponential Fitness' official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	56.82%	30.73%	0.76%
EBITDA Growth	244.69%	194.78%	-162.57%
EBIT Growth	105.16%	1,895.78%	-272.21%
NOPAT Growth	142.79%	164.67%	-253.60%
Net Income Growth	102.14%	-685.20%	-1,431.83%
EPS Growth	69.12%	40.91%	-336.54%
Operating Cash Flow Growth	260.28%	-37.17%	-64.30%
Free Cash Flow Firm Growth	44.34%	349.61%	9.76%
Invested Capital Growth	12.25%	-3.35%	-37.31%
Revenue Q/Q Growth	9.03%	6.07%	-1.95%
EBITDA Q/Q Growth	-18.39%	27.80%	-192.62%
EBIT Q/Q Growth	-67.47%	58.10%	-11,155.06%
NOPAT Q/Q Growth	170.04%	37.41%	-3,667.13%
Net Income Q/Q Growth	104.15%	-192.11%	-119.02%
EPS Q/Q Growth	82.44%	-333.33%	-582.98%
Operating Cash Flow Q/Q Growth	8.47%	-37.56%	43.40%
Free Cash Flow Firm Q/Q Growth	0.00%	1,066.24%	237.82%
Invested Capital Q/Q Growth	10.24%	-1.70%	-35.38%
Profitability Metrics	-	-	-
Gross Margin	80.90%	76.00%	74.63%
EBITDA Margin	7.25%	16.36%	-10.16%
Operating Margin	5.48%	10.98%	-16.74%
EBIT Margin	0.65%	9.97%	-17.05%
Profit (Net Income) Margin	0.45%	-2.03%	-30.81%
Tax Burden Percent	69.29%	119.12%	99.65%
Interest Burden Percent	100.00%	-17.06%	181.35%
Effective Tax Rate	30.71%	0.00%	0.00%
Return on Invested Capital (ROIC)	4.91%	12.51%	-24.02%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.86%	-3.51%	-44.37%
Return on Net Nonoperating Assets (RNNOA)	-3.59%	-263.16%	92.35%
Return on Equity (ROE)	1.32%	-250.65%	68.33%
Cash Return on Invested Capital (CROIC)	-6.63%	15.92%	21.85%
Operating Return on Assets (OROA)	0.35%	6.27%	-11.71%
Return on Assets (ROA)	0.25%	-1.27%	-21.16%
Return on Common Equity (ROCE)	-6.43%	13,884.67%	81.98%
Return on Equity Simple (ROE_SIMPLE)	-0.71%	4.96%	45.57%
Net Operating Profit after Tax (NOPAT)	9.23	24	-38
NOPAT Margin	3.80%	7.69%	-11.72%
Net Nonoperating Expense Percent (NNEP)	7.77%	16.01%	20.34%
Return On Investment Capital (ROIC_SIMPLE)	-12.82%	21.34%	-103.32%
Cost of Revenue to Revenue	19.10%	24.00%	25.37%
SG&A Expenses to Revenue	52.14%	53.11%	55.21%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	68.05%	65.02%	91.36%
Earnings before Interest and Taxes (EBIT)	1.59	32	-55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	18	52	-33
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.64	1.92	0.00
Price to Earnings (P/E)	928.88	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.11%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	7.46	4.86	0.00
Enterprise Value to Revenue (EV/Rev)	6.09	2.94	0.00
Enterprise Value to EBITDA (EV/EBITDA)	84.00	17.95	0.00
Enterprise Value to EBIT (EV/EBIT)	932.71	29.44	0.00
Enterprise Value to NOPAT (EV/NOPAT)	160.54	38.22	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	28.47	28.54	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	30.03	0.00
Leverage & Solvency	-	-	-
Debt to Equity	1.36	-3.42	-1.79
Long-Term Debt to Equity	1.33	-3.37	-1.76
Financial Leverage	1.26	75.01	-2.08
Leverage Ratio	5.40	196.89	-3.23
Compound Leverage Factor	5.40	-33.58	-5.86
Debt to Total Capital	57.64%	141.40%	226.69%
Short-Term Debt to Total Capital	1.29%	2.08%	3.52%
Long-Term Debt to Total Capital	56.35%	139.32%	223.17%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	107.92%	15.33%	14.74%
Common Equity to Total Capital	-65.56%	-56.73%	-141.43%
Debt to EBITDA	7.71	6.23	-10.67
Net Debt to EBITDA	5.59	5.52	-9.66
Long-Term Debt to EBITDA	7.54	6.14	-10.50
Debt to NOPAT	14.74	13.26	-9.25
Net Debt to NOPAT	10.69	11.74	-8.38
Long-Term Debt to NOPAT	14.41	13.07	-9.11
Altman Z-Score	0.45	-0.30	0.00
Noncontrolling Interest Sharing Ratio	586.20%	5,639.43%	-19.97%
Liquidity Ratios	-	-	-
Current Ratio	1.18	0.95	0.78
Quick Ratio	0.89	0.67	0.60
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-12	31	34
Operating Cash Flow to CapEx	920.83%	496.10%	304.56%
Free Cash Flow to Firm to Interest Expense	-0.96	0.80	0.74
Operating Cash Flow to Interest Expense	4.00	0.84	0.25
Operating Cash Flow Less CapEx to Interest Expense	3.57	0.67	0.17
Efficiency Ratios	-	-	-
Asset Turnover	0.54	0.63	0.69
Accounts Receivable Turnover	13.06	11.12	10.12
Inventory Turnover	5.22	5.77	6.35
Fixed Asset Turnover	15.54	16.72	18.76
Accounts Payable Turnover	2.99	4.39	3.56
Days Sales Outstanding (DSO)	27.96	32.81	36.06
Days Inventory Outstanding (DIO)	69.90	63.26	57.49
Days Payable Outstanding (DPO)	122.15	83.23	102.45
Cash Conversion Cycle (CCC)	-24.29	12.84	-8.90
Capital & Investment Metrics	-	-	-
Invested Capital	199	192	120
Invested Capital Turnover	1.29	1.63	2.05
Increase / (Decrease) in Invested Capital	22	-6.66	-72
Enterprise Value (EV)	1,482	934	0.00
Market Capitalization	1,129	612	0.00
Book Value per Share	($3.14)	($2.74)	($6.77)
Tangible Book Value per Share	($9.30)	($8.87)	($14.15)
Total Capital	236	229	153
Total Debt	136	324	347
Total Long-Term Debt	133	319	342
Net Debt	99	287	314
Capital Expenditures (CapEx)	5.65	6.59	3.83
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-21	-38	-51
Debt-free Net Working Capital (DFNWC)	16	-0.49	-18
Net Working Capital (NWC)	13	-5.25	-24
Net Nonoperating Expense (NNE)	8.13	31	61
Net Nonoperating Obligations (NNO)	99	287	314
Total Depreciation and Amortization (D&A)	16	20	22
Debt-free, Cash-free Net Working Capital to Revenue	-8.79%	-11.82%	-15.95%
Debt-free Net Working Capital to Revenue	6.58%	-0.16%	-5.73%
Net Working Capital to Revenue	5.33%	-1.65%	-7.41%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.87)	$1.18	($2.27)
Adjusted Weighted Average Basic Shares Outstanding	25.30M	31.74M	32.00M
Adjusted Diluted Earnings per Share	($0.87)	($0.44)	($2.27)
Adjusted Weighted Average Diluted Shares Outstanding	25.30M	39.71M	32.00M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.27M	47.49M	48.48M
Normalized Net Operating Profit after Tax (NOPAT)	12	36	6.26
Normalized NOPAT Margin	4.84%	11.37%	1.95%
Pre Tax Income Margin	0.65%	-1.70%	-30.92%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.12	0.82	-1.18
NOPAT to Interest Expense	0.71	0.63	-0.81
EBIT Less CapEx to Interest Expense	-0.31	0.65	-1.26
NOPAT Less CapEx to Interest Expense	0.27	0.46	-0.89
Payout Ratios	-	-	-
Dividend Payout Ratio	1,511.72%	-300.06%	-14.88%
Augmented Payout Ratio	1,511.72%	-1,081.96%	-14.88%

This table displays calculated financial ratios and metrics derived from Xponential Fitness' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	56.03%	40.80%	40.36%	29.85%	26.15%	28.71%	12.49%	-1.06%	0.07%	-6.32%
EBITDA Growth	780.64%	33.15%	74.86%	0.85%	-29.67%	120.66%	572.01%	-93.15%	-111.76%	-1,543.90%
EBIT Growth	417.21%	31.36%	47.47%	-1.07%	-46.01%	89.64%	187.35%	-107.44%	-214.98%	-2,630.04%
NOPAT Growth	417.21%	31.36%	51.22%	7.45%	-28.32%	90.16%	202.51%	-104.65%	-185.93%	-2,769.53%
Net Income Growth	-46.63%	92.81%	1.32%	-12.56%	60.30%	-544.79%	70.92%	-149.64%	-246.71%	-354.24%
EPS Growth	-302.63%	167.21%	8.61%	-82.00%	67.32%	-23.49%	78.26%	-422.22%	42.00%	-209.45%
Operating Cash Flow Growth	230.22%	38.64%	293.04%	-17.56%	-32.35%	-137.56%	-76.26%	-84.38%	-31.59%	113.90%
Free Cash Flow Firm Growth	94.32%	0.00%	94.60%	8.07%	-4.90%	115.57%	-75.77%	-99.04%	146.08%	552.07%
Invested Capital Growth	10.23%	12.25%	2.87%	1.87%	8.39%	-3.35%	12.60%	-1.00%	-4.63%	-37.31%
Revenue Q/Q Growth	7.06%	9.02%	-0.81%	9.41%	4.00%	11.24%	-11.83%	-3.78%	5.19%	4.13%
EBITDA Q/Q Growth	-61.98%	-202.05%	76.10%	1,621.89%	-73.48%	-70.03%	11.86%	-77.93%	-145.55%	-3,580.36%
EBIT Q/Q Growth	-71.13%	-277.10%	53.43%	560.70%	-84.25%	-133.98%	137.61%	-139.25%	-143.40%	-706.75%
NOPAT Q/Q Growth	-78.37%	-277.10%	-126.15%	819.10%	-85.57%	-124.31%	150.53%	-132.59%	-166.86%	-711.83%
Net Income Q/Q Growth	-141.48%	83.60%	-3,981.47%	283.75%	-118.83%	-166.35%	52.00%	-213.64%	-31.53%	-248.96%
EPS Q/Q Growth	-406.00%	208.50%	-182.63%	106.52%	-655.56%	354.00%	-122.22%	3.33%	0.00%	-379.31%
Operating Cash Flow Q/Q Growth	-51.61%	29.41%	-20.06%	69.27%	-60.29%	-171.84%	197.22%	11.35%	73.91%	-85.40%
Free Cash Flow Firm Q/Q Growth	-131.20%	-267.60%	-322.45%	422.20%	-130.29%	154.55%	-994.96%	101.76%	1,357.36%	671.89%
Invested Capital Q/Q Growth	-7.64%	10.24%	-8.27%	9.07%	-1.74%	-1.70%	3.25%	-4.11%	-5.34%	-35.38%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	73.89%	103.01%	74.44%	76.81%	79.78%	73.13%	75.46%	75.56%	72.74%	74.79%
EBITDA Margin	24.05%	-22.51%	-3.78%	52.58%	13.41%	3.61%	15.86%	3.64%	-1.58%	-55.68%
Operating Margin	16.36%	-26.58%	-10.20%	47.13%	9.30%	-2.03%	9.29%	-3.15%	-7.98%	-62.24%
EBIT Margin	16.36%	-26.58%	-10.98%	46.23%	7.00%	-2.14%	8.52%	-3.48%	-8.05%	-62.34%
Profit (Net Income) Margin	-20.48%	-3.08%	-21.19%	35.59%	-6.44%	-15.43%	-5.48%	-17.85%	-22.33%	-74.82%
Tax Burden Percent	97.70%	143.21%	99.19%	99.52%	104.06%	106.33%	98.93%	100.98%	100.73%	99.12%
Interest Burden Percent	-128.09%	8.09%	194.59%	77.35%	-88.43%	678.32%	-64.95%	508.46%	275.42%	121.08%
Effective Tax Rate	0.00%	0.00%	0.00%	0.48%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	14.86%	-24.09%	-10.53%	67.40%	10.39%	-2.31%	10.99%	-3.64%	-9.57%	-89.34%
ROIC Less NNEP Spread (ROIC-NNEP)	-8.65%	-13.77%	-16.24%	61.96%	4.85%	-8.81%	7.40%	-8.25%	-14.20%	-98.05%
Return on Net Nonoperating Assets (RNNOA)	-8.78%	-17.32%	-506.88%	277.49%	-3,382.81%	-661.16%	-27.46%	34.69%	41.25%	204.10%
Return on Equity (ROE)	6.08%	-41.41%	-517.41%	344.89%	-3,372.42%	-663.47%	-16.47%	31.05%	31.68%	114.76%
Cash Return on Invested Capital (CROIC)	0.00%	-6.63%	4.18%	6.32%	1.42%	15.92%	12.96%	6.46%	5.29%	21.85%
Operating Return on Assets (OROA)	8.74%	-14.39%	-6.34%	25.95%	4.10%	-1.34%	5.62%	-2.23%	-5.14%	-42.81%
Return on Assets (ROA)	-10.94%	-1.67%	-12.23%	19.98%	-3.77%	-9.69%	-3.61%	-11.43%	-14.25%	-51.38%
Return on Common Equity (ROCE)	-18.70%	201.32%	19,440.70%	-1,040.78%	-1,660,464.63%	36,752.58%	-42.31%	78.06%	46.50%	137.68%
Return on Equity Simple (ROE_SIMPLE)	20.89%	0.00%	-1.38%	0.55%	-5.06%	0.00%	-6.17%	21.24%	28.94%	0.00%
Net Operating Profit after Tax (NOPAT)	7.30	-13	-5.04	36	5.23	-1.27	5.17	-1.69	-4.50	-37
NOPAT Margin	11.45%	-18.61%	-7.14%	46.91%	6.51%	-1.42%	6.50%	-2.20%	-5.59%	-43.57%
Net Nonoperating Expense Percent (NNEP)	23.51%	-10.31%	5.70%	5.44%	5.54%	6.50%	3.59%	4.61%	4.63%	8.71%
Return On Investment Capital (ROIC_SIMPLE)	-	17.97%	-	-	-	-1.11%	-	-	-	-100.53%
Cost of Revenue to Revenue	26.11%	-3.01%	25.56%	23.19%	20.23%	26.87%	24.54%	24.44%	27.26%	25.21%
SG&A Expenses to Revenue	51.50%	44.19%	49.35%	48.11%	54.59%	59.08%	46.72%	48.34%	57.35%	67.46%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	90.25%	73.78%	84.64%	29.67%	70.48%	75.16%	66.17%	78.71%	80.73%	137.03%
Earnings before Interest and Taxes (EBIT)	10	-18	-7.76	36	5.63	-1.91	6.78	-2.66	-6.48	-52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	15	-16	-2.67	41	11	3.23	13	2.78	-1.27	-47
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.00	4.64	5.64	3.02	2.58	1.92	2.40	2.30	1.83	0.00
Price to Earnings (P/E)	5,760.62	928.88	0.00	845.56	162.47	0.00	126.42	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.02%	0.11%	0.00%	0.12%	0.62%	0.00%	0.79%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	6.66	7.46	10.44	6.10	5.67	4.86	5.53	5.58	5.04	0.00
Enterprise Value to Revenue (EV/Rev)	5.38	6.09	7.17	4.28	3.70	2.94	3.47	3.36	2.88	0.00
Enterprise Value to EBITDA (EV/EBITDA)	55.52	84.00	44.92	27.93	27.23	17.95	13.34	23.29	26.74	0.00
Enterprise Value to EBIT (EV/EBIT)	245.75	932.71	83.80	52.67	55.25	29.44	22.25	87.17	1,901.64	0.00
Enterprise Value to NOPAT (EV/NOPAT)	351.06	160.54	151.11	75.24	62.32	38.22	23.61	101.87	892.89	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	25.01	28.47	31.64	21.63	21.15	28.54	42.41	104.11	115.36	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	253.29	97.35	415.61	30.03	45.20	85.95	92.98	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.76	1.36	-5.09	-11.51	-4.21	-3.42	-3.54	-3.21	-2.82	-1.79
Long-Term Debt to Equity	1.72	1.33	-5.01	-11.33	-4.14	-3.37	-3.48	-3.16	-2.77	-1.76
Financial Leverage	1.02	1.26	31.22	4.48	-697.91	75.01	-3.71	-4.20	-2.91	-2.08
Leverage Ratio	4.90	5.40	82.36	14.02	-1,898.89	196.89	-6.94	-8.26	-5.11	-3.23
Compound Leverage Factor	-6.27	0.44	160.26	10.85	1,679.10	1,335.56	4.51	-42.01	-14.07	-3.91
Debt to Total Capital	63.79%	57.64%	124.46%	109.51%	131.14%	141.40%	139.35%	145.21%	155.04%	226.69%
Short-Term Debt to Total Capital	1.44%	1.29%	2.02%	1.78%	2.10%	2.08%	2.21%	2.31%	2.41%	3.52%
Long-Term Debt to Total Capital	62.36%	56.35%	122.43%	107.73%	129.04%	139.32%	137.14%	142.90%	152.63%	223.17%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	96.38%	107.92%	81.43%	56.80%	24.80%	15.33%	22.78%	22.97%	14.45%	14.74%
Common Equity to Total Capital	-60.17%	-65.56%	-105.89%	-66.31%	-55.94%	-56.73%	-62.13%	-68.18%	-69.48%	-141.43%
Debt to EBITDA	6.23	7.71	6.18	6.03	7.97	6.23	3.81	6.86	9.89	-10.67
Net Debt to EBITDA	4.80	5.59	5.52	5.11	6.69	5.52	3.49	6.31	8.81	-9.66
Long-Term Debt to EBITDA	6.09	7.54	6.08	5.93	7.84	6.14	3.75	6.75	9.74	-10.50
Debt to NOPAT	39.40	14.74	20.80	16.25	18.24	13.26	6.74	30.01	330.23	-9.25
Net Debt to NOPAT	30.36	10.69	18.57	13.75	15.32	11.74	6.17	27.59	294.33	-8.38
Long-Term Debt to NOPAT	38.51	14.41	20.46	15.98	17.94	13.07	6.63	29.53	325.10	-9.11
Altman Z-Score	0.00	0.32	0.33	0.04	-0.23	-0.51	-0.28	-0.46	-0.69	0.00
Noncontrolling Interest Sharing Ratio	407.34%	586.20%	3,857.30%	401.77%	-49,136.55%	5,639.43%	-156.92%	-151.38%	-46.78%	-19.97%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.99	1.18	1.02	0.96	1.15	0.95	0.95	0.93	1.02	0.78
Quick Ratio	0.65	0.89	0.67	0.68	0.80	0.67	0.64	0.61	0.72	0.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-9.42	-35	-10	33	-9.88	5.39	-18	0.31	4.55	35
Operating Cash Flow to CapEx	0.00%	540.08%	592.74%	927.32%	528.69%	-470.88%	1,382.05%	146.39%	297.55%	0.00%
Free Cash Flow to Firm to Interest Expense	-2.83	-8.75	-1.27	3.78	-0.93	0.47	-1.54	0.03	0.38	3.03
Operating Cash Flow to Interest Expense	3.38	3.69	1.42	2.23	0.72	-0.48	0.23	0.27	0.44	0.07
Operating Cash Flow Less CapEx to Interest Expense	3.51	3.01	1.18	1.99	0.58	-0.58	0.22	0.08	0.29	0.08
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.54	0.58	0.56	0.59	0.63	0.66	0.64	0.64	0.69
Accounts Receivable Turnover	16.91	13.06	13.86	12.12	12.73	11.12	11.99	11.51	11.41	10.12
Inventory Turnover	6.58	5.22	6.30	5.32	4.61	5.77	5.34	6.04	6.07	6.35
Fixed Asset Turnover	15.39	15.54	16.04	15.55	16.24	16.72	16.97	16.45	16.70	18.76
Accounts Payable Turnover	3.24	2.99	4.50	2.41	2.93	4.39	3.45	3.08	3.60	3.56
Days Sales Outstanding (DSO)	21.58	27.96	26.33	30.11	28.67	32.81	30.45	31.73	31.99	36.06
Days Inventory Outstanding (DIO)	55.47	69.90	57.90	68.60	79.09	63.26	68.39	60.48	60.14	57.49
Days Payable Outstanding (DPO)	112.63	122.15	81.19	151.18	124.75	83.23	105.95	118.68	101.32	102.45
Cash Conversion Cycle (CCC)	-35.58	-24.29	3.04	-52.47	-16.98	12.84	-7.10	-26.48	-9.18	-8.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	180	199	182	199	195	192	205	197	186	120
Invested Capital Turnover	1.30	1.29	1.48	1.44	1.60	1.63	1.69	1.65	1.71	2.05
Increase / (Decrease) in Invested Capital	17	22	5.08	3.66	15	-6.66	23	-2.00	-9.05	-72
Enterprise Value (EV)	1,200	1,482	1,902	1,212	1,108	934	1,135	1,099	939	0.00
Market Capitalization	893	1,129	1,497	855	774	612	785	750	597	0.00
Book Value per Share	($2.60)	($3.14)	($4.52)	($3.20)	($2.77)	($2.74)	($3.04)	($3.16)	($3.23)	($6.77)
Tangible Book Value per Share	($8.84)	($9.30)	($10.62)	($9.16)	($8.53)	($8.87)	($9.32)	($9.05)	($9.06)	($14.15)
Total Capital	211	236	210	239	247	229	232	223	224	153
Total Debt	135	136	262	262	324	324	324	324	347	347
Total Long-Term Debt	132	133	258	257	319	319	319	318	342	342
Net Debt	104	99	234	222	272	287	297	298	310	314
Capital Expenditures (CapEx)	-0.41	2.70	1.92	2.07	1.44	1.16	0.20	2.05	1.75	-0.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-28	-21	-22	-40	-31	-38	-27	-27	-31	-51
Debt-free Net Working Capital (DFNWC)	2.49	16	6.11	0.40	21	-0.49	0.54	-0.96	6.83	-18
Net Working Capital (NWC)	-0.54	13	1.85	-3.86	16	-5.25	-4.61	-6.11	1.43	-24
Net Nonoperating Expense (NNE)	20	-11	9.93	8.75	10	13	9.53	12	13	26
Net Nonoperating Obligations (NNO)	104	99	234	222	272	287	297	298	310	314
Total Depreciation and Amortization (D&A)	4.90	2.83	5.09	4.91	5.15	5.15	5.83	5.45	5.21	5.59
Debt-free, Cash-free Net Working Capital to Revenue	-12.73%	-8.79%	-8.30%	-14.06%	-10.38%	-11.82%	-8.15%	-8.26%	-9.47%	-15.95%
Debt-free Net Working Capital to Revenue	1.12%	6.58%	2.30%	0.14%	6.93%	-0.16%	0.16%	-0.29%	2.09%	-5.73%
Net Working Capital to Revenue	-0.24%	5.33%	0.70%	-1.36%	5.19%	-1.65%	-1.41%	-1.87%	0.44%	-7.41%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.53)	($1.12)	($1.38)	$1.44	$0.91	$0.11	($0.30)	($0.29)	($0.29)	($1.39)
Adjusted Weighted Average Basic Shares Outstanding	26.16M	25.30M	30.75M	33.05M	32.26M	31.74M	31.13M	31.81M	32.18M	32.00M
Adjusted Diluted Earnings per Share	($1.53)	$1.66	($1.38)	$0.09	($0.50)	$1.27	($0.30)	($0.29)	($0.29)	($1.39)
Adjusted Weighted Average Diluted Shares Outstanding	26.16M	25.30M	30.75M	41.59M	40.22M	39.71M	31.13M	31.81M	32.18M	32.00M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.22M	49.27M	49.56M	49.97M	47.46M	47.49M	48.07M	48.18M	48.30M	48.48M
Normalized Net Operating Profit after Tax (NOPAT)	7.30	-13	-5.04	43	8.50	-1.27	5.17	6.78	-1.35	-37
Normalized NOPAT Margin	11.45%	-18.61%	-7.14%	56.22%	10.57%	-1.42%	6.50%	8.86%	-1.67%	-43.57%
Pre Tax Income Margin	-20.96%	-2.15%	-21.36%	35.76%	-6.19%	-14.51%	-5.54%	-17.68%	-22.16%	-75.48%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.13	-4.67	-0.97	4.14	0.53	-0.17	0.59	-0.24	-0.55	-4.50
NOPAT to Interest Expense	2.19	-3.27	-0.63	4.21	0.49	-0.11	0.45	-0.15	-0.38	-3.15
EBIT Less CapEx to Interest Expense	3.25	-5.35	-1.21	3.90	0.39	-0.27	0.57	-0.42	-0.70	-4.49
NOPAT Less CapEx to Interest Expense	2.31	-3.95	-0.87	3.97	0.36	-0.21	0.43	-0.33	-0.53	-3.13
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-67.34%	1,511.72%	412.85%	-1,098.41%	234.62%	-300.06%	230.99%	-59.03%	-39.01%	-14.88%
Augmented Payout Ratio	-66.82%	1,511.72%	412.85%	-1,098.41%	954.82%	-1,081.96%	230.99%	-59.03%	-39.01%	-14.88%

Financials Breakdown Chart

Key Financial Trends

Here is a concise trend snapshot of Xponential Fitness (NYSE: XPOF) based on the quarterly statements provided (covering 2022–2024). The focus is on notable patterns in the income statement, cash flow, and balance sheet from the last four years.

Gross margin has remained solidly in the mid-to-high 70% range across 2024 quarters, with gross profit around 58–63M on 80–84M in revenue (example: Q4 2024 gross margin about 75%).
Positive cash generation from continuing operations occurred in several quarters, indicating ongoing operating liquidity despite reported net losses (for example, Q3 2024 and Q2 2024 show meaningful net cash from continuing operating activities).
There are periods of positive net cash from operating activities across the four-year window (e.g., Q4 2022 and Q3 2024), suggesting intermittent improvement in operating cash flow.
The balance sheet carries substantial goodwill and intangible assets (goodwill around 165–173M and intangible assets around 117–125M in 2023–2024), which can support brand value but may pose impairment risk if performance falters.
Redeemable noncontrolling interests are sizable (roughly in the 110–130M range in recent quarters), signaling a complex capital structure with minority interests that may affect future returns or dilution considerations.
Revenue demonstrates quarterly volatility and seasonality typical of a multi-brand fitness model, with peaks in some quarters (e.g., Q4 2023) followed by softer results in others (e.g., late 2024).
Net income is consistently negative across the observed quarters, culminating in a large quarterly loss of about 62.7M in Q4 2024, highlighting ongoing profitability challenges.
Total operating expenses are very high and, in several quarters, exceed gross profit, driving significant operating losses (example: Q4 2024 shows total operating expenses around 114.9M versus gross profit of 62.7M).
The balance sheet shows high leverage, with total liabilities well over assets in multiple periods and substantial long-term debt, accompanied by negative equity in several quarters—indicating a fragile capital position.
Interest expense remains a meaningful drag each quarter (roughly 11–12M per quarter), contributing to net losses and reducing cash flow from operations.

Bottom line: Xponential Fitness has managed to maintain strong gross margins and occasional operational cash generation, but it faces continued profitability and balance-sheet headwinds from high operating costs, heavy leverage, and sizable minority interests. Investors should watch whether the company can stabilize earnings, reduce fixed costs, and improve overall leverage over the next several quarters.

05/21/26 03:16 PM ETAI Generated. May Contain Errors.

Xponential Fitness Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Xponential Fitness' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

Xponential Fitness' net income appears to be on an upward trend, with a most recent value of -$98.70 million in 2024, falling from $1.10 million in 2022. The previous period was -$6.44 million in 2023. Check out Xponential Fitness' forecast to explore projected trends and price targets.

Xponential Fitness' total operating income in 2024 was -$53.61 million, based on the following breakdown:

Total Gross Profit: $239.06 million
Total Operating Expenses: $292.68 million

Over the last 2 years, Xponential Fitness' total revenue changed from $243.20 million in 2022 to $320.35 million in 2024, a change of 31.7%.

Xponential Fitness' total liabilities were at $597.40 million at the end of 2024, a 4.3% decrease from 2023, and a 56.1% increase since 2022.

In the past 2 years, Xponential Fitness' cash and equivalents has ranged from $32.74 million in 2024 to $37.37 million in 2022, and is currently $32.74 million as of their latest financial filing in 2024.

Over the last 2 years, Xponential Fitness' book value per share changed from -3.14 in 2022 to -6.77 in 2024, a change of 115.2%.

Related Companies

Financial statements for NYSE:XPOF last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xponential Fitness (XPOF) Financials

Financials Breakdown Chart

Key Financial Trends

Xponential Fitness Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Xponential Fitness (XPOF) Financials

Annual Income Statements for Xponential Fitness

Quarterly Income Statements for Xponential Fitness

Annual Cash Flow Statements for Xponential Fitness

Quarterly Cash Flow Statements for Xponential Fitness

Annual Balance Sheets for Xponential Fitness

Quarterly Balance Sheets for Xponential Fitness

Annual Metrics And Ratios for Xponential Fitness

Quarterly Metrics And Ratios for Xponential Fitness

Financials Breakdown Chart

Key Financial Trends

Xponential Fitness Financials - Frequently Asked Questions

When does Xponential Fitness' fiscal year end?

How has Xponential Fitness' net income changed over the last 2 years?

What is Xponential Fitness' operating income?

How has Xponential Fitness' revenue changed over the last 2 years?

How much debt does Xponential Fitness have?

How much cash does Xponential Fitness have?

How has Xponential Fitness' book value per share changed over the last 2 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools